EBioMedicine
EBioMedicine is a leading biomedical open access journal, bridging the gap between basic and clinical research, published by The Lancet.
EBioMedicine is a leading biomedical open access journal, bridging the gap between basic and clinical research, published by The Lancet.
The notable health differences between females and males point to an urgent need for policies to be based on sex-specific and age-specific data. It is…
Since the adoption of the Sustainable Development Goals in 2015, our world has transformed substantially. Despite this change, the approaches to addressing maternal health challenges…
Vasculitides have long posed significant diagnostic and therapeutic challenges for clinicians due to their complex nature. During the past two decades, the mechanisms driving these…
A huge global inequality related to cancer is the difference in overall survival of children with cancer in low-income and middle-income countries (LMICs; survival rates…
In pregnant women starting with tighter glycaemic control, AHCL therapy did not improve overall time in target range but improved overnight time in target range,…
The role of hybrid closed-loop systems in the clinical management of type 1 diabetes is rapidly expanding. Randomised controlled trials have shown life-changing clinical and…
Vasculitides have long posed significant diagnostic and therapeutic challenges for clinicians due to their complex nature. During the past two decades, the mechanisms driving these…
Multiple myeloma is a malignancy of plasma cells, which is highly associated with immune suppression. Consistent with this, reports of outcomes of COVID-19 infection in…
The regional availability of community perinatal mental health teams reduced the postnatal risk of acute relapse and increased the overall use of secondary mental health…
Lenalidomide plus low-dose dexamethasone is associated with better short-term overall survival and with lower toxicity than lenalidomide plus high-dose dexamethasone in patients with newly diagnosed…